Clinical Trials Logo

HCC clinical trials

View clinical trials related to HCC.

Filter by:
  • Not yet recruiting  
  • « Prev · Page 3

NCT ID: NCT03199807 Not yet recruiting - HCC Clinical Trials

Phase IB/II Study of NRT Combined With Radiotherapy for Advanced HCC

LCRAI-1
Start date: July 20, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

The study herein successfully developed a new immunotherapeutic approach combined with radiotherapy, and tried to proved it to be more effective and safe.

NCT ID: NCT02715492 Not yet recruiting - HCC Clinical Trials

Role of (LMWH) in Prevention of Thromboembolic Complication After (TACE) in Hepatocellular Carcinoma.

Start date: October 2018
Phase: Phase 3
Study type: Interventional

Hepatocellular carcinoma (HCC) is a major health problem worldwide, and most cases are inoperable because of late presentation and underlying cirrhosis. It represents the fifth most common tumor in the world and the third most frequent cause of mortality amongst patients with cancer. Due to the worldwide difficulties in finding liver for transplantation, hepatic resection (HR) represents the main stay of curative treatment for patients with HCC. Transcatheter arterial chemoembolization (TACE) is widely used as alternative treatments for unresectable HCC or for patients not eligible to be operated on . TACE also could be an adjuvant therapy for resectable HCC patients after hepatectomy, which could prevent recurrence and improve long-term survival .

NCT ID: NCT02561546 Not yet recruiting - Diabetes Clinical Trials

p53 Gene Therapy in Treatment of Diabetes Concurrent With Hepatocellular Carcinoma

Start date: December 2015
Phase: Phase 2
Study type: Interventional

An open-labeled phase II study to investigate preliminary efficacy using p53 gene therapy in treatment of diabetes concurrent with hepatocellular carcinoma (HCC).

NCT ID: NCT02415283 Not yet recruiting - HCC Clinical Trials

OBT Measurement to Differentiate Between Presence and Absence of HCC Determined by MRI

Start date: May 2015
Phase: Phase 2
Study type: Observational

The Exalenz clinical investigation is a multicenter, non-randomized, study of the ¹³C-Octanoate Breath Test (OBT). The present study is a feasibility trial, which aims to evaluate the capability of the OBT to differentiate between presence and absence of HCC determined by Magnetic Resonance Imaging (MRI) in patients with chronic liver disease.